BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27339449)

  • 21. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
    Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
    J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer.
    Hanna PE; Wang Q; Strohbehn IA; Moreno D; Harden D; Ouyang T; Katz-Agranov N; Seethapathy H; Reynolds KL; Gupta S; Leaf DE; Sise ME
    JAMA Netw Open; 2023 Jul; 6(7):e2321715. PubMed ID: 37405775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
    Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
    Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities.
    Åkesson A; Lindström V; Nyman U; Jonsson M; Abrahamson M; Christensson A; Björk J; Grubb A
    Scand J Clin Lab Invest; 2020 Sep; 80(5):412-422. PubMed ID: 32459111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.
    Carrero JJ; Fu EL; Sang Y; Ballew S; Evans M; Elinder CG; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
    Am J Kidney Dis; 2023 Nov; 82(5):534-542. PubMed ID: 37354936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.
    Chen DC; Lu K; Scherzer R; Lees JS; Rutherford E; Mark PB; Potok OA; Rifkin DE; Ix JH; Shlipak MG; Estrella MM
    Kidney Med; 2024 Apr; 6(4):100796. PubMed ID: 38567244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to estimate kidney function in kidney transplant recipients with mild to moderate kidney impairment: comparison of estimated glomerular filtration (eGFR) values between creatinine-based GFR equations and cystatin C-based GFR equations for Japanese population.
    Tsujita M; Goto N; Yamamoto T; Hiramitsu T; Nanmoku K; Inaguma D; Takeda A; Kobayashi T; Tominaga Y; Morozumi K; Uchida K; Watarai Y
    Clin Exp Nephrol; 2014 Feb; 18(1):130-4. PubMed ID: 23670303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive effect of estimated glomerular filtrate rate by creatinine or cystatin C on mortality in patients with coronary artery disease.
    Chen S; Zhou Y; Liang G; Wu W; Huang Z; Shi L; Gao Y; Gu X; Wang D
    Ren Fail; 2024 Dec; 46(1):2327494. PubMed ID: 38566467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
    Meeusen JW; Rule AD; Voskoboev N; Baumann NA; Lieske JC
    Clin Chem; 2015 Oct; 61(10):1265-72. PubMed ID: 26240296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applicability of chronic kidney disease epidemiology collaboration equations in a Chinese population.
    Zhang M; Chen Y; Tang L; Zhang J; Liu S; Wang S; Wei R; Zhou J; Cao X; Zhang W; Zhang J; Yang Y; Cai G; Sun X; Chen X
    Nephrol Dial Transplant; 2014 Mar; 29(3):580-6. PubMed ID: 24335503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of estimated glomerular filtration rate from serum creatinine and cystatin C with new-onset diabetes: a nationwide cohort study in China.
    Zhang Z; He P; Zhou C; Liu M; Liu C; Li H; Zhang Y; Li Q; Zhang Y; Wang G; Liang M; Qin X
    Acta Diabetol; 2021 Sep; 58(9):1269-1276. PubMed ID: 33909121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordance Between Creatinine-Based and Cystatin C-Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR.
    Wang Y; Adingwupu OM; Shlipak MG; Doria A; Estrella MM; Froissart M; Gudnason V; Grubb A; Kalil R; Mauer M; Rossing P; Seegmiller J; Coresh J; Levey AS; Inker LA
    Kidney Med; 2023 Oct; 5(10):100710. PubMed ID: 37753251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.
    Rule AD; Bailey KR; Lieske JC; Peyser PA; Turner ST
    Kidney Int; 2013 Jun; 83(6):1169-76. PubMed ID: 23423253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of cystatin C- and creatinine-based eGFR with osteoporotic fracture in Japanese postmenopausal women with osteoporosis: sarcopenia as risk for fracture.
    Kurajoh M; Inaba M; Nagata Y; Yamada S; Imanishi Y; Emoto M
    J Bone Miner Metab; 2019 Mar; 37(2):282-291. PubMed ID: 29464358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
    Grams ME; Juraschek SP; Selvin E; Foster MC; Inker LA; Eckfeldt JH; Levey AS; Coresh J
    Am J Kidney Dis; 2013 Aug; 62(2):253-60. PubMed ID: 23619125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in novel filtration markers and risk of ESRD.
    Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
    Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystatin C, chronic kidney disease and retinopathy in adults without diabetes.
    Ng WY; Teo BW; Tai ES; Sethi S; Lamoureux E; Tien Yin W; Sabanayagam C
    Eur J Prev Cardiol; 2016 Sep; 23(13):1413-20. PubMed ID: 26928726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Estimated Glomerular Filtration Rate with Both Serum Creatinine and Cystatin C (eGFRcr-cys) versus Single Analyte (eGFRcr or eGFRcys) Using CKD-EPI and MDRD Equations in Tertiary Care Hospital Settings.
    Khalid UB; Haroon ZH; Aamir M; Ain QU; Mansoor K; Jaffar SR
    J Coll Physicians Surg Pak; 2020 Jul; 30(7):701-706. PubMed ID: 32811598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.